The objective of this study is to demonstrate the safety and efficacy of IC14 in the
treatment of hospitalized patients with community-acquired pneumonia and sepsis.
- Current diagnosis of community-acquired pneumonia.
- Evidence of systemic inflammatory response to infection.
- Atypical or viral pneumonia based on clinical or epidemiologic suspicion by the
- Presence of organ failure.